<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03978936</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00197194</org_study_id>
    <secondary_id>1R01HL136945-01A1</secondary_id>
    <secondary_id>3R01HL136945-01A1S1</secondary_id>
    <nct_id>NCT03978936</nct_id>
  </id_info>
  <brief_title>Medication Adherence With Telehealthcare Medication Therapy Management</brief_title>
  <acronym>MATCH</acronym>
  <official_title>Improving Medication Adherence With Telehealthcare Medication Therapy Management to Change Health Outcomes in Adolescents and Young Adults With Asthma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Nemours Children's Health System</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>American Lung Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Improving Medication Adherence with Telehealthcare Medication Therapy Management to Change&#xD;
      Health Outcomes in Adolescents and Young Adults with Asthma (MATCH) is a multi-center,&#xD;
      randomized parallel group study targeted to an at-risk population of Adolescents and Young&#xD;
      Adults (AYA) with uncontrolled asthma who have poor adherence with prescribed Inhaled&#xD;
      corticosteroid (ICS) therapy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study evaluates a Medication Therapy Management (MTM) video telehealthcare intervention&#xD;
      to address poor medication adherence. In addition, it employs a novel method to track and&#xD;
      provide feedback to participants on adherence by using Propeller Sensors. 300 adolescents and&#xD;
      young adults will be randomized to Medication Therapy Management (MTM) video telehealthcare&#xD;
      plus electronic adherence self-management [MTM EAM] or electronic adherence self-management&#xD;
      alone (EAM). Due to the hierarchal design of the trial, two primary outcomes to be tested in&#xD;
      a sequential manner are specified, adherence and time to first asthma exacerbation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 18, 2019</start_date>
  <completion_date type="Anticipated">September 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized, parallel, superiority trial with two intervention groups</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time (days) to first exacerbation event</measure>
    <time_frame>12 months</time_frame>
    <description>Time to first asthma exacerbation is the time to first exacerbation event defined as a worsening of asthma requiring the use of systemic corticosteroids for at least 3 days, or asthma-specific emergency department visit with treatment with systemic corticosteroids, or asthma-specific hospitalization, or death (all cause and asthma exacerbation). 104. These data will be collected by self-report in the &quot;My Asthma&quot; bi-weekly assessment questionnaire, and verified by the study site coordinator with the participant's provider.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Proportion of adherent days as assessed by Propeller sensors</measure>
    <time_frame>12 months</time_frame>
    <description>Adherence will be measured using data collected from Propeller sensors. Adherence for each day is calculated as the number of inhalations taken divided by the expected number of doses. A day will be defined as adherent if the participant completes 80% or more of the prescribed inhalations. The primary outcome will be the proportion of adherent days over the course of follow-up, i.e. from the randomization visit to the 1-year visit.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Uncontrolled Asthma</condition>
  <condition>Young Adults</condition>
  <arm_group>
    <arm_group_label>MTM-EAM</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Medication Therapy Management Video Telehealthcare plus Electronic Adherence Self-Management [MTM-EAM]</description>
  </arm_group>
  <arm_group>
    <arm_group_label>EAM only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Electronic Adherence Self-Management [EAM] only</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Medication Therapy Management (MTM) Video Telehealthcare</intervention_name>
    <description>MTM is an individualized approach to &quot;optimize medication use for improved patient outcomes&quot; and is designed to &quot;empower patients to take an active role in managing patients' medications&quot; thus, providing a favorable strategy for addressing adherence issues. Five core elements define MTM: complete medication therapy review (CMR), creation of a personal medication list (PML), development of a medication action plan (MAP), intervention and/or referral for drug therapy problems, and documentation and follow-up</description>
    <arm_group_label>MTM-EAM</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Electronic Adherence Self-Management (EAM)</intervention_name>
    <description>Participants will have a sensor which monitors their adherence to medication use</description>
    <arm_group_label>EAM only</arm_group_label>
    <arm_group_label>MTM-EAM</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 14 through 30 years&#xD;
&#xD;
          -  Speaks English or Spanish&#xD;
&#xD;
          -  Physician diagnosed asthma (without any other co-morbid pulmonary disease)&#xD;
&#xD;
          -  Prescribed ICS treatment for at least 6 months prior to screening&#xD;
&#xD;
          -  Adherence to Refills and Medication Scale (ARMS) 7-item questionnaire score of &gt;8 (low&#xD;
             or moderate adherence)&#xD;
&#xD;
          -  Current use of albuterol metered dose inhaler (MDI) for rescue: ProAir, Ventolin,&#xD;
             Xopenex&#xD;
&#xD;
          -  Uncontrolled asthma:&#xD;
&#xD;
          -  Symptomatic asthma defined as 3 of the following in the past 4 weeks:&#xD;
&#xD;
          -  Daytime symptoms of asthma more than twice per week&#xD;
&#xD;
          -  Any night awakening due to asthma&#xD;
&#xD;
          -  Rescue inhaler use for symptoms more than twice per week&#xD;
&#xD;
          -  Any activity limitation due to asthma; OR&#xD;
&#xD;
          -  Asthma Control Test score â‰¤19&#xD;
&#xD;
          -  Has iPhone or Android smart phone with Short Message Service (SMS)&#xD;
&#xD;
          -  Has access to reliable WiFi service and a device with capability for telemedicine&#xD;
             study visits&#xD;
&#xD;
          -  Ability to understand and willingness to sign consent documents&#xD;
&#xD;
          -  Evidence of Propeller sensor connection in the 4-week run-in period&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Use of an investigational treatment in the previous 30 days.&#xD;
&#xD;
          -  Previous enrollment in MATCH Structured Interviews ( Aim 1)&#xD;
&#xD;
          -  Currently enrolled in an intervention trial&#xD;
&#xD;
          -  Currently uses an ICS not compatible with the Propeller sensor&#xD;
&#xD;
          -  Inability to comply with study procedures, including:&#xD;
&#xD;
          -  Inability or unwillingness to provide informed consent (or assent in the case of a&#xD;
             minor).&#xD;
&#xD;
          -  Inability to perform study measurements.&#xD;
&#xD;
          -  inability to be contacted by phone via calls and /or text messaging&#xD;
&#xD;
          -  Not willing to have video chat&#xD;
&#xD;
          -  Any condition(s) in the opinion of the physician that puts the participant at risk&#xD;
             from participating in the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kathryn Blake, Pharm.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nemours Children's Specialty Care</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Robert Wise, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins School of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Janet Holbrook, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins Bloomberg School of Public Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Heather Hazucha, MPH</last_name>
    <phone>410-502-0585</phone>
    <email>hhazuch1@jhu.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35249</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>University of Arizona</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85724</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>University of California at San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Julian Silva</last_name>
      <phone>415-476-5418</phone>
      <email>julian.silva@ucsf.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>National Jewish Medical and Research Center</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80206</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>Nemours Children's Specialty Care</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32207</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelle Littlefield</last_name>
      <phone>904-697-3092</phone>
      <email>Michelle.Littlefield@nemours.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Florida College of Medicine</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32209</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Fallon Wainwright</last_name>
      <phone>904-244-1106</phone>
      <email>fallon.wainwright@jax.ufl.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Illinois at Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60608</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ben Xu</last_name>
      <phone>312-942-5987</phone>
      <email>ben_xu@rush.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jia(Grace) Li</last_name>
      <phone>312-942-8701</phone>
      <email>Jia_li@rush.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University of Chicago Hospitals</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>St Vincent Indianapolis Hospital</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46260</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>St. Vincent Hospital and Health Care Center, Inc.</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46260</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ellen Looney</last_name>
      <phone>317-338-8030</phone>
      <email>Jloon002@ascension.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Kansas Medical Center</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pamela Kemp</last_name>
      <phone>913-588-6045</phone>
      <email>pkemp3@kumc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Vanessa Curtis</last_name>
      <phone>913-588-6045</phone>
      <email>vcurtis@kumc.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109-5360</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Laurie Carpenter</last_name>
      <phone>734-615-7825</phone>
      <email>lauriemc@med.umich.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Children's Mercy Hospital</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64108</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Miguel A Bahena-Garcia</last_name>
      <phone>816-302-3377</phone>
      <email>mabahenagarcia@cmh.edu</email>
    </contact>
    <contact_backup>
      <last_name>Danielle Wolfe</last_name>
      <phone>816-302-3378</phone>
      <email>dmwolfe@cmh.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>New York University School of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Brittany Marti</last_name>
      <phone>212-263-2252</phone>
      <email>Brittany.Marti@nyulangone.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>Mount Sinai National Jewish Health Respiratory Institute; Icahn School of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Chelsea Chung</last_name>
      <phone>212-241-8655</phone>
      <email>Chelsea.chung@mssm.edu</email>
    </contact>
    <contact_backup>
      <last_name>Stephanie Pagan</last_name>
      <phone>332-215-2854</phone>
      <email>stephanie.pagan@mssm.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>Temple University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19140</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sylvia Johnson</last_name>
      <phone>215-707-4679</phone>
      <email>sylvia.johnson@tuhs.temple.edu</email>
    </contact>
    <contact_backup>
      <last_name>Melissa Navarro</last_name>
      <phone>215-707-5481</phone>
      <email>Melissa.Navarro@tuhs.temple.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Baylor College of Medicine</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Laura Bertrand</last_name>
      <phone>713-798-2681</phone>
      <email>laura.bertrand@bcm.tmc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vermont Lung Center at The University of Vermont</name>
      <address>
        <city>Colchester</city>
        <state>Vermont</state>
        <zip>05466</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>Pacific Northwest Airways - VA Puget Sound Healthcare System</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98108</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Emily Gleason</last_name>
      <phone>206-277-6739</phone>
      <email>Emily.Gleason@va.gov</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>June 5, 2019</study_first_submitted>
  <study_first_submitted_qc>June 5, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 7, 2019</study_first_posted>
  <last_update_submitted>March 15, 2021</last_update_submitted>
  <last_update_submitted_qc>March 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Bronchial Diseases</keyword>
  <keyword>Respiratory Tract Diseases</keyword>
  <keyword>Lung Diseases</keyword>
  <keyword>Obstructive Lung Diseases</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

